Lamin A/C Is a Risk Biomarker in Colorectal Cancer
2008

Lamin A/C as a Risk Biomarker in Colorectal Cancer

Sample size: 658 publication 10 minutes Evidence: high

Author Information

Author(s): Willis Naomi D., Cox Thomas R., Rahman-Casañs Syed F., Smits Kim, Przyborski Stefan A., van den Brandt Piet, van Engeland Manon, Weijenberg Matty, Wilson Robert G., de Bruïne Adriaan, Hutchison Christopher J.

Primary Institution: School of Biological and Biomedical Sciences, Durham University, Durham, United Kingdom

Hypothesis

Does the expression of A-type lamins influence tumor progression and patient prognosis in colorectal cancer?

Conclusion

Patients with A-type lamin-expressing tumors have a significantly worse prognosis than those without.

Supporting Evidence

  • Expression of A-type lamins in colorectal cancer tissues is correlated with a two-fold increase in mortality risk.
  • Patients with A-type lamin positive tumors had a hazard ratio of 1.85 for CRC-related death.
  • Expression of lamin A promotes increased cell motility and invasiveness in colorectal cancer cell lines.

Takeaway

This study found that a protein called lamin A can help predict how likely someone is to die from colorectal cancer, as it makes the cancer more aggressive.

Methodology

The study screened colorectal cancer and normal colon tissue for A-type lamin expression and analyzed patient survival using Cox proportional hazard ratios.

Potential Biases

Potential biases in patient selection and tissue sample availability.

Limitations

The study is limited to a specific cohort and may not generalize to all populations.

Participant Demographics

Patients from the Netherlands Cohort Study on Diet and Cancer, with a focus on colorectal cancer.

Statistical Information

P-Value

0.005

Confidence Interval

95% C.I. 1.16–2.97

Statistical Significance

p=0.005

Digital Object Identifier (DOI)

10.1371/journal.pone.0002988

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication